Ubs Asset Management Americas Inc Arvinas, Inc. Transaction History

Ubs Asset Management Americas Inc

$379 Billion
Q1 2025

A detailed history of Ubs Asset Management Americas Inc transactions in Arvinas, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 902,925 shares of ARVN stock, worth $5.88 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

902,925

Previous 433,531 108.27%

Holding current value

$5.88 Million

Previous $8.31 Million 23.73%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 19, 2025	BUY	$7.02 - $20.5 $3.3 Million - $9.62 Million	469,394 Added 108.27%	902,925 $6.34 Million
Q4 2024 Feb 14, 2025	BUY	$17.83 - $28.04 $54,328 - $85,437	3,047 Added 0.71%	433,531 $8.31 Million
Q3 2024 Nov 14, 2024	SELL	$23.66 - $32.73 $16,372 - $22,649	-692 Reduced 0.16%	430,484 $10.6 Million
Q2 2024 Aug 13, 2024	BUY	$24.46 - $40.4 $5.79 Million - $9.56 Million	236,680 Added 121.69%	431,176 $11.5 Million
Q1 2024 May 15, 2024	SELL	$36.38 - $52.31 $1.39 Million - $1.99 Million	-38,121 Reduced 16.39%	194,496 $8.03 Million
Q4 2023 Feb 14, 2024	BUY	$14.19 - $42.33 $1.02 Million - $3.04 Million	71,911 Added 44.75%	232,617 $9.57 Million
Q3 2023 Nov 13, 2023	SELL	$19.64 - $28.21 $17,047 - $24,486	-868 Reduced 0.54%	160,706 $3.16 Million
Q1 2023 May 15, 2023	SELL	$26.15 - $37.26 $159,907 - $227,844	-6,115 Reduced 3.65%	161,574 $4.41 Million
Q4 2022 Feb 14, 2023	BUY	$32.47 - $57.24 $294,567 - $519,281	9,072 Added 5.72%	167,689 $5.74 Million
Q3 2022 Nov 14, 2022	BUY	$41.87 - $57.99 $4.5 Million - $6.23 Million	107,473 Added 210.14%	158,617 $7.06 Million
Q2 2022 Aug 12, 2022	BUY	$36.01 - $74.24 $191,825 - $395,476	5,327 Added 11.63%	51,144 $2.15 Million
Q1 2022 May 16, 2022	BUY	$60.27 - $81.57 $147,360 - $199,438	2,445 Added 5.64%	45,817 $3.08 Million
Q4 2021 Feb 14, 2022	BUY	$65.85 - $96.21 $63,347 - $92,554	962 Added 2.27%	43,372 $3.56 Million
Q3 2021 Nov 15, 2021	SELL	$73.2 - $107.87 $117,120 - $172,592	-1,600 Reduced 3.64%	42,410 $3.49 Million
Q2 2021 Aug 16, 2021	BUY	$60.45 - $84.26 $676,858 - $943,459	11,197 Added 34.12%	44,010 $3.39 Million
Q1 2021 May 14, 2021	BUY	$58.19 - $91.37 $513,526 - $806,340	8,825 Added 36.79%	32,813 $2.17 Million
Q4 2020 Mar 01, 2021	SELL	$20.19 - $84.93 $3.32 Million - $13.9 Million	-164,219 Reduced 87.25%	23,988 $2.04 Million
Q3 2020 Nov 13, 2020	SELL	$22.99 - $36.34 $6.24 Million - $9.87 Million	-271,576 Reduced 59.07%	188,207 $4.44 Million
Q2 2020 Aug 14, 2020	BUY	$29.88 - $56.74 $4.55 Million - $8.65 Million	152,413 Added 49.59%	459,783 $15.4 Million
Q1 2020 May 15, 2020	BUY	$33.0 - $54.5 $9.95 Million - $16.4 Million	301,370 Added 5022.83%	307,370 $12.4 Million
Q4 2019 Feb 14, 2020	BUY	$15.39 - $44.38 $92,340 - $266,280	6,000 New	6,000 $246,000

Others Institutions Holding ARVN

# of Institutions

246

Shares Held

62.5M

Call Options Held

2.65M

Put Options Held

1.1M

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $346M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Arvinas, Inc. Transaction History